Alloy Therapeutics and University of British Columbia Partner to Accelerate Antibody Discovery with Cryo-Electron Microscopy Technology
Boston, MA and Vancouver, BC, October 2, 2025 — Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, and the University of British Columbia (UBC) announced a collaboration under which the two organizations will partner to accelerate the discovery of novel antibody therapeutics for pandemic preparedness applications. […]
米アロイ・セラピューティクス、 湘南ヘルスイノベーションパークに新拠点を設立
– 米バイオテクノロジー企業、アロイ・セラピューティクスが日本初の子会社を設立
– 主要モダリティである細胞治療の研究拠点を初めて日本に開設し、独自のiCAR-T技術を本格的に展開
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform
Collaboration builds on Alloy’s existing and highly productive engagement with Pfizer and will apply Alloy’s innovation expertise to address Pfizer’s specific antibody discovery objectives